NEJM 2026年10月15日刊新内容: Lonvoguran Ziclumeran 治疗遗传性血管性水肿(3期 HAELO 试验)https://nej.md/4gaSsbi Ponatinib–Blinatumomab 治疗 Ph 阳性 ALL(3期 GIMEMA ALL2820 试验)https://nej.md/4scorw0 Icotrokinra 治疗溃疡性结肠炎患者(ANTHEM-UC 试验)https://nej.md/4hLHjhO 长效 HIV 疗法在非洲成人中的应用(3b期 IMPALA 试验)https://nej.md/4jWdqMY 订阅 NEJM 获取最新医学研究:https://nej.md/subscribe
New in the October 15, 2026, issue of NEJM:
Lonvoguran Ziclumeran in Hereditary Angioedema (phase 3 HAELO trial) https://nej.md/4gaSsbi
Ponatinib–Blinatumomab for Ph-Positive ALL (phase 3 GIMEMA ALL2820 trial) https://nej.md/4scorw0
Icotrokinra for Patients with Ulcerative Colitis (ANTHEM-UC trial) https://nej.md/4hLHjhO
Long-Acting HIV Therapy in African Adults (phase 3b IMPALA trial) https://nej.md/4jWdqMY
Subscribe to NEJM for the latest medical research: https://nej.md/subscribe
来源:NEJM · x.com